Modulation of glucose metabolism and metabolic connectivity by β-amyloid

Cascading network failure across the Alzheimer’s disease spectrum

(2015) David T. Jones et al.   BRAIN

Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images

(2015) F. Carbonell et al.   JOURNAL OF NUCLEAR MEDICINE

Beta-Amyloid Associated Differential Effects of APOE ε4 on Brain Metabolism in Cognitively Normal Elderly

(2014) Dahyun Yi et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Amyloid Imaging in Aging and Dementia: Testing the Amyloid HypothesisIn Vivo

(2014) G. D. Rabinovici et al.   BEHAVIOURAL NEUROLOGY

FDG-PET and amyloid-PET imaging

(2014) Daniela Perani   CURRENT OPINION IN NEUROLOGY

β-Amyloid is Associated with Aberrant Metabolic Connectivity in Subjects with Mild Cognitive Impairment

(2014) Felix Carbonell et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Hierarchical Multivariate Covariance Analysis of Metabolic Connectivity

(2014) Felix Carbonell et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis

(2014) Y. Liu et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Association of hypometabolism and amyloid levels in aging, normal subjects

(2014) V. J. Lowe et al.   NEUROLOGY

Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”

(2014) Daniela Perani et al.   Biomed Research International

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients

(2013) M. Lehmann et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

(2013) C. R. Jack et al.   NEUROLOGY

Biomarker Modeling of Alzheimer’s Disease

(2013) Clifford R. Jack et al.   NEURON

Brain injury biomarkers are not dependent on β-amyloid in normal elderly

(2012) David S. Knopman et al.   ANNALS OF NEUROLOGY

Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly

(2012) Hwamee Oh et al.   HUMAN BRAIN MAPPING

Apolipoprotein E, Not Fibrillar  -Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging

(2012) W. J. Jagust et al.   JOURNAL OF NEUROSCIENCE

Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects

(2012) A. D. Joshi et al.   JOURNAL OF NUCLEAR MEDICINE

Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project

(2012) Silvia Morbelli et al.   NEUROBIOLOGY OF AGING

Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses

(2012) Paule-Joanne Toussaint et al.   NEUROIMAGE

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

(2011) Clifford R. Jack et al.   ANNALS OF NEUROLOGY

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

(2011) Christopher M. Clark   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Erroneous analyses of interactions in neuroscience: a problem of significance

(2011) Sander Nieuwenhuis et al.   NATURE NEUROSCIENCE

Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls

(2010) D.P. Devanand et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

(2010) Ahmadul Kadir et al.   NEUROBIOLOGY OF AGING

Comparing predictors of conversion and decline in mild cognitive impairment

(2010) S. M. Landau et al.   NEUROLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Reducing between scanner differences in multi-center PET studies

(2009) Aniket Joshi et al.   NEUROIMAGE